Annual Drug Patent Expirations for ALIQOPA
Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has one hundred and forty-one patent family members in fifty countries.
The generic ingredient in ALIQOPA is copanlisib dihydrochloride. One supplier is listed for this compound. Additional details are available on the copanlisib dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
